Catalytic nanovaccine for cancer immunotherapy: A NADPH oxidase-inspired Fe-polyphenol network nanovaccine for enhanced antigen cross-presentation.

MLA

Chong, Gaowei, et al. “Catalytic Nanovaccine for Cancer Immunotherapy: A NADPH Oxidase-Inspired Fe-Polyphenol Network Nanovaccine for Enhanced Antigen Cross-Presentation.” Chemical Engineering Journal, vol. 435, May 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.cej.2022.134993.

APA

Chong, G., Su, R., Gu, J., Yang, Y., Zhang, T., Zang, J., Zhao, Y., Zheng, X., Liu, Y., Ruan, S., He, R., Yin, W., Li, Y., Dong, H., & Li, Y. (2022). Catalytic nanovaccine for cancer immunotherapy: A NADPH oxidase-inspired Fe-polyphenol network nanovaccine for enhanced antigen cross-presentation. Chemical Engineering Journal, 435, N.PAG. https://doi.org/10.1016/j.cej.2022.134993

Chicago

Chong, Gaowei, Runping Su, Jingjing Gu, Yushan Yang, Tingting Zhang, Jie Zang, Yuge Zhao, et al. 2022. “Catalytic Nanovaccine for Cancer Immunotherapy: A NADPH Oxidase-Inspired Fe-Polyphenol Network Nanovaccine for Enhanced Antigen Cross-Presentation.” Chemical Engineering Journal 435 (May): N.PAG. doi:10.1016/j.cej.2022.134993.